For example, the decreasing trend of igfbp1 and igfbp7 gene expression may reduce IGF-1 bioactivity, potentially leading to decreased igfr expression [41], which results in metabolic disorders and inadequate energy supply in the liver. This evidence concerns the gene IGF1 and metabolic disease.